About Paradigm Biopharmaceuticals
paradigm’s (asx: par) immediate commercial focus is the repurposing of pentosan polysulfate sodium (pps) for the treatment of osteoarthritis (oa). this is a global unmet need and we ... Read more
paradigm’s (asx: par) immediate commercial focus is the repurposing of pentosan polysulfate sodium (pps) for the treatment of osteoarthritis (oa). this is a global unmet need and we ... Read more